PH25819A - Linear, cyclic analog of alpha-msh fragments with extraordinary potency - Google Patents

Linear, cyclic analog of alpha-msh fragments with extraordinary potency

Info

Publication number
PH25819A
PH25819A PH36969A PH36969A PH25819A PH 25819 A PH25819 A PH 25819A PH 36969 A PH36969 A PH 36969A PH 36969 A PH36969 A PH 36969A PH 25819 A PH25819 A PH 25819A
Authority
PH
Philippines
Prior art keywords
linear
alpha
cyclic analog
extraordinary potency
msh fragments
Prior art date
Application number
PH36969A
Other languages
English (en)
Inventor
Victor J Hruby
Fahad A Al-Obeidi
Mac E Hadley
Original Assignee
Victor J. Hruby
Fahad A. Al-Obeidi
Mac E. Hadley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victor J. Hruby, Fahad A. Al-Obeidi, Mac E. Hadley filed Critical Victor J. Hruby
Publication of PH25819A publication Critical patent/PH25819A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Steroid Compounds (AREA)
PH36969A 1987-05-22 1988-05-23 Linear, cyclic analog of alpha-msh fragments with extraordinary potency PH25819A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5322987A 1987-05-22 1987-05-22
CA000578920A CA1340107C (fr) 1987-05-22 1988-09-30 Analoques lineaires et cycliques de fragments alpha-msh possedant une puissance enorme

Publications (1)

Publication Number Publication Date
PH25819A true PH25819A (en) 1991-11-05

Family

ID=25672150

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36969A PH25819A (en) 1987-05-22 1988-05-23 Linear, cyclic analog of alpha-msh fragments with extraordinary potency

Country Status (11)

Country Link
EP (1) EP0292291B1 (fr)
JP (1) JPH0826077B2 (fr)
CN (1) CN1031242C (fr)
AT (1) ATE109793T1 (fr)
CA (1) CA1340107C (fr)
DE (1) DE3851002T2 (fr)
DK (1) DK172760B1 (fr)
FI (1) FI882380A (fr)
IE (1) IE64903B1 (fr)
PH (1) PH25819A (fr)
PT (1) PT87560B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683981A (en) * 1987-05-22 1997-11-04 Competitive Technologies, Inc. Cyclic bridged analogs of α-MSH and methods thereof
US5674839A (en) * 1987-05-22 1997-10-07 Competitive Technologies, Inc. Cyclic analogs of alpha-MSH fragments
EP0389950A1 (fr) * 1989-03-23 1990-10-03 Lion Corporation Inhibiteur de l'hormone stimulant les mélanocytes et préparation à usage externe la contenant
US5071583A (en) * 1990-08-14 1991-12-10 Steve Martell Soap bar having a fifth finger gripping member
GB9102450D0 (en) * 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5364851A (en) * 1991-06-14 1994-11-15 International Synthecon, Llc Conformationally restricted biologically active peptides, methods for their production and uses thereof
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
WO1994022460A1 (fr) * 1993-04-05 1994-10-13 University Patents, Inc. Diagnostic et traitement des dysfonctionnements erectiles
FR2710340B1 (fr) * 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .
US5726156A (en) * 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5420109A (en) * 1993-11-12 1995-05-30 Houghten Pharmaceuticals, Inc. Cytokine restraining agents
US5786332A (en) * 1995-03-06 1998-07-28 Trega Biosciences, Inc. Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
CA2368431C (fr) 1999-03-29 2006-01-24 The Procter & Gamble Company Ligands du recepteur de melanocortine
TW200716979A (en) * 1999-06-29 2007-05-01 Univ New York Screening methods for compounds that affect melanogenesis
DE10228837B4 (de) * 2002-06-27 2016-01-07 Elfriede Rauch Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel
CA2539596A1 (fr) 2003-09-30 2005-04-07 Kilian Waldemar Conde-Frieboes Nouveaux agonistes du recepteur de la melanocortine
NZ554427A (en) * 2004-10-08 2010-09-30 Clinuvel Pharmaceuticals Ltd Compositions and methods for inducing melanogenesis in a subject utilising afamelanotide
CN100355776C (zh) * 2005-06-20 2007-12-19 中国人民解放军第二军医大学 一种新型α－黑素细胞刺激素类似物及其用途
JP2009500426A (ja) 2005-07-08 2009-01-08 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス メラノコルチン受容体のリガンド
PT2957292T (pt) 2008-03-27 2018-02-09 Clinuvel Pharmaceuticals Ltd Terapia de vitiligo
AU2009257631B2 (en) 2008-06-09 2014-07-24 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
WO2010022249A2 (fr) 2008-08-20 2010-02-25 Ensemble Discovery Corporation Composés destinés à l’inhibition du facteur de nécrose tumorale alpha
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
CA2781402C (fr) 2009-11-23 2017-03-21 Palatin Technologies, Inc. Peptides cycliques specifiques du recepteur de la melanocortine-1
JP2013511554A (ja) 2009-11-23 2013-04-04 パラティン テクノロジーズ，インコーポレイテッド メラノコルチン−１受容体特異的線状ペプチド
CN102816211B (zh) * 2012-09-10 2014-07-23 南京工业大学 一种制备美那诺坦的方法
EP2970388B1 (fr) * 2013-03-15 2018-07-25 Rhythm Pharmaceuticals, Inc. Compositions de peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US448539A (en) 1891-03-17 Cornelius s morris
US4457864A (en) * 1981-10-23 1984-07-03 University Patents, Inc. Synthetic analogues of α-melanotropin
US4485039A (en) * 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin

Also Published As

Publication number Publication date
EP0292291A3 (en) 1990-05-02
DK172760B1 (da) 1999-06-28
AU618733B2 (en) 1992-01-09
JPS6470499A (en) 1989-03-15
PT87560B (pt) 1992-09-30
FI882380A (fi) 1988-11-23
DK277788D0 (da) 1988-05-20
CN1031242C (zh) 1996-03-13
JPH0826077B2 (ja) 1996-03-13
AU1650688A (en) 1988-11-24
DE3851002T2 (de) 1995-02-02
PT87560A (pt) 1989-05-31
EP0292291B1 (fr) 1994-08-10
EP0292291A2 (fr) 1988-11-23
CA1340107C (fr) 1998-10-27
IE881537L (en) 1988-11-22
DK277788A (da) 1988-11-23
IE64903B1 (en) 1995-09-20
FI882380A0 (fi) 1988-05-20
ATE109793T1 (de) 1994-08-15
CN1032795A (zh) 1989-05-10
DE3851002D1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
PH25819A (en) Linear, cyclic analog of alpha-msh fragments with extraordinary potency
EP0259440A4 (fr) Procede de stimulation de melanocytes par l'application topique d'analogues d'alpha-msh, et compositions utilisees.
PL266680A1 (en) Method of obtaining il-6 and of its application
DE68929551D1 (de) Menschliche DNase
ZA85206B (en) Protein conjugates useful in the treatment of thrombotic disease
AU1362488A (en) Topical composition and method for stimulating hair growth with stable free radicals
IL85712A0 (en) Lyophilized lymphokine composition
EP0214254A1 (fr) Compositions de melatonine et leurs utilisations.
GB8819826D0 (en) Glycosylated igf-1
DE3685484D1 (fr)
NZ214702A (en) Using interferon in treatments and pharmaceutical compositions
ZA85973B (en) Hardenable composition and its use
NO863027D0 (no) Peptidpreparater med kontinuerlig avgivelse.
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
DE3572441D1 (en) Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
MY104115A (en) Linear and cyclic analogs of alpha-msh fragments with extraordinary potency
NZ224348A (en) Tanning composition with al and ti
HK1006971A1 (en) Linear and cyclic analogs of alpha-msh fragments with extraordinary potency
AU618733C (en) Linear and cyclic analogs of alpha-MSH fragments with extraordinary potency
IT8848116A0 (it) Composizione farmaceutica in particolare per il trattamento di alopecia e acne vulgaris e procedimento per prepararla
JO1437B1 (en) Anesthetic composition that affects the skin for topical use and its method of preparation
EP0195114A3 (en) Stabilized injection compositions and their preparations
NZ216361A (en) Azetidine derivatives and pharmaceutical compositions
DK173286D0 (da) Skinneholder til stroemskinner i elektriske skinnefelter og tavleanlaeg
GB2268062B (en) Use of gamma amino butyric acid autoreceptor antagonists for the treatment of pain